Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X0002 in Knee Osteoarthritis Pain (Phase II, China)
CTR20180594Phase 2Completed
- Sponsor
- Tianjin Xinchen Taifeier Pharmaceutical Technology
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofenamine hydrochloride in knee osteoarthritis (OA), sponsored by Tianjin Xinchen Taifeier Pharmaceutical Technology. Started Aug 2018; status: completed.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20180594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180594.